MedPath

Efficacy of Healature spray versus Oxum spray in Fistulectomy wound

Phase 3
Not yet recruiting
Registration Number
CTRI/2023/11/060069
Lead Sponsor
Dr Dhruv Bhadreshbhai Modi
Brief Summary

The volunteers will be informed about the study protocol. willing participant will be randomly selected as per computer generated table. Clinical research format will be prepared and validated. Prior to the study approval will be taken from IEC, MGACHRC, Salod(H), Wardha and CTRI registration will be done. After selection ,each participant will be tested individually and selected according to selection criteria. they will be divided into two groups as the trial is a parallel group, randomized, open clinical, standard controlled trial. it will include a 16 days treatment period and follow up.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Patients of both the sexes in between the age group of 18 to 60 years.
  • Patients irrespective of gender, religion, occupation and economic status.
  • Complete fistulectomy wounds of length 1-3 cm will be included in this study.
  • Patients with controlled hypertension and diabetes mellitus.
Exclusion Criteria
  • Patients having Fistula in ano secondary to Ulcerative colitis, Syphilis, Crohn’s disease, Tuberculosis and malignancy of rectum and anal canal.
  • Pregnant females HIV& HbsAg positive patients Skin diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fistulectomy wound healing14 days
Secondary Outcome Measures
NameTimeMethod
relief in pain, reduces itching14 days

Trial Locations

Locations (1)

Mahatma Gandhi Ayurved College Hospital & Research Centre

🇮🇳

Wardha, MAHARASHTRA, India

Mahatma Gandhi Ayurved College Hospital & Research Centre
🇮🇳Wardha, MAHARASHTRA, India
Dr Dhruv Bhadreshbhai Modi
Principal investigator
9426691684
modidhruv1997@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.